EC seeks comment on GMP for active substances
The EC has published its latest concept paper designed to invite comment on the implementation of last year’s falsified medicines directive, this time looking at GMP for active substances.
Other News
Discovery of miltefosine fakes highlights need for simple assays
The discovery of counterfeit generic miltefosine capsules for the treatment of visceral leishmaniasis serves to underscore the urgent need for simple, inexpensive assays to evaluate medicines quality in the field.Pakistan shuts down pharma facility after deaths
The authorities in Pakistan have shut down a manufacturing facility in Punjab on suspicion of producing substandard and potentially spurious medicines that have killed dozens of people, according to local news reports.US generic drug user fee proposals mean more facilities inspections
Manufacturers of APIs and finished dosage forms destined for the US market will be subject to more frequent inspections if Congress adopts the FDA's proposals for a new a Generic Drug User Fee Act.Counterfeit antimalarials in Africa on the rise, caution scientists
Researchers are recommending "multiple parallel strategies" to stave off an alarming rise in fake and substandard antimalarials in Africa.Pharma cargo thefts decline in 2011
The number of thefts of pharmaceutical shipments declined significantly in 2011, with fewer cases and a much lower average value per incident, according to data compiled by security firm Freightwatch.US counterfeit drug seizures up 200 per cent in 2011
Seizures of counterfeit pharmaceuticals by US customs almost tripled in 2011 compared to the previous year, thanks in part to greater enforcement activity. The value of goods seized rose by $11m to reach $16.8m.
News in brief
Nigeria seeks mandatory life terms for medicine counterfeiters
UK teen dies of Internet pill overdose
Verify Brand unveils new traceability software version
Vesdo test labels help verify datamatrix reader systems
EDQM suspends five API certificates
CDPA bill clears Senate Judiciary Committee
Gillespie appeal bid rejected by UK High Court
Pharma label specialist ATL licenses authentication tech from DSS
Around the web
-
Anatomy of a GTIN: RxTrace
-
EU needs united approach to fight fake drugs: WSJ
-
‘True’ serialization must involve the patient: Healthcare Packaging
-
California BoP and the FDA - authentication throughout the supply Chain: PMPN
-
Why GS1 EPCIS alone won’t work for California pedigree, Part 2: RxTrace
-
Impact of RxUSA v. HHS on future pedigree legislation: RxTrace
-
Many doctors part of fake drug syndicate: India Today




